［1］Chevet B, Chiche L Y, Devauchelle-Pensec V, et al. How rare is primary Sjögren's syndrome?［J］. Joint Bone Spine, 2023, 90(1): 105480.
［2］Levitt D G, Levitt M D. Protein-losing enteropathy: a comprehensive review of the mechanistic association with clinical and subclinical disease states［J］. Clin Exp Gastroenterol, 2017, 10: 147－168.
［3］Seror R, Ravaud P, Bowman S J, et al. EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome［J］. Ann Rheum Dis, 2010, 69(6): 1103－1109.
［4］Savoca M L, Brownell J N. Comprehensive nutrition guidelines and management strategies for enteropathy in children［J］. Semin Pediatr Surg, 2024, 33(3): 151425.
［5］Craven M D, Washabau R J. Comparative pathophysiology and management of protein-losing enteropathy［J］. J Vet Intern Med, 2019, 33(2): 383－402.
［6］Ozen A, Can S, Sefer A P, et al. Complement dysregulation at lymphatics［J］. J Allergy Clin Immunol, 2025, 156(2): 205－214.
［7］Akaishi T, Yasaka K, Abe M, et al. Protein-losing gastroenteropathy with severe hypoalbuminemia associated with Sjögren's syndrome: a case report and review of the literature［J］. J Gen Fam Med, 2019, 21(1): 24－28.
［8］Law S T, Ma K M, Li K K. Protein-losing enteropathy associated with or without systemic autoimmune disease: what are the differences?［J］. Eur J Gastroenterol Hepatol, 2012, 24(3): 294－302.
［9］Mok C C, Ying K Y, Mak A, et al. Outcome of protein-losing gastroenteropathy in systemic lupus erythematosus treated with prednisolone and azathioprine［J］. Rheumatology, 2006, 45(4): 425－429.
［10］Chen Z, Li M T, Xu D, et al. Protein-losing enteropathy in systemic lupus erythematosus: 12 years experience from a Chinese academic center［J］. PLoS One, 2014, 9(12): e114684.
［11］De Carvalho J F, Lerner A, Gonçalves C M, et al. Sjögren syndrome associated with protein-losing enteropathy: case-based review［J］. Clin Rheumatol, 2021, 40(6): 2491－2497.
［12］Li Z, Xu D, Wang Z, et al. Gastrointestinal system involvement in systemic lupus erythematosus［J］. Lupus, 2017, 26(11): 1127－1138.
［13］Tsutsumi A, Sugiyama T, Matsumura R, et al. Protein losing enteropathy associated with collagen diseases［J］. Ann Rheum Dis, 1991, 50(3): 178－181.
［14］Nakajima A, Ohnishi S, Mimura T, et al. Protein-losing enteropathy associated with hypocomplementemia and anti-nuclear antibodies［J］. J Gastroenterol, 2000, 35(8): 627－630.
［15］Itoi K, Sasaki T, Sawai T, et al. Protein-losing gastroenteropathy in association with immune deposits in gastrointestinal mucosal capillaries［J］. Am J Gastroenterol, 1989, 84(2): 187－191.
［16］Uraoka Y, Tanigawa T, Watanabe K, et al. Complete remission of protein-losing gastroenteropathy associated with Sjogren's syndrome by B cell-targeted therapy with rituximab［J］. Am J Gastroenterol, 2012, 107(8): 1266－1268.
［17］Lewis J S, Sharma A, Horton J B, et al. Lupus-associated protein losing enteropathy (LUPLE) complicated by a hypercoagulable state and successfully treated with belimumab［J］. Clin J Gastroenterol, 2020, 13(5): 771－774.
|
